Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AARP To Re-Launch “Wise Use” Drug Comparison Campaign In 2006

This article was originally published in The Pink Sheet Daily

Executive Summary

The campaign will provide consumers and prescribers with price and effectiveness comparisons for prescription, generic and over-the-counter drugs within the same class. It will be an extension of the group’s 2003 effort.

AARP will re-launch its "wise use" drug campaign in 2006 by providing price and effectiveness comparisons for prescription, generic and over-the-counter drugs within the same class.

"In our new 'wise use' campaign we're going to give consumers and health professionals additional information that describes the comparative effectiveness and the price of different medications - brand, generic and over-the-counter - that can be used to treat a condition," AARP CEO Bill Novelli said.

Novelli spoke at the World Congress Leadership Summit on Disease Management & Chronic Care April 5 in Arlington, Va.

"We're going to roll this campaign out starting next year and build on our efforts to put a spotlight on prescription drug prices and inflation trends."

"We initiated the campaign in 2003 to urge our members and the public to talk to their doctors about their prescriptions... and to ask their doctors if generic drugs are available," Novelli said.

The campaign featured television and magazine advertisements advising consumers to compare drug prices and consider generic therapies.

"We're planning to restart this campaign and crank it up a notch."

The campaign will complement the group's recently launched drug comparison website, which includes comparisons of effectiveness, safety and cost for nine classes of drugs. The site will eventually have information on 20 classes of drugs (1 (Also see "AARP Drug Website Includes Effectiveness, Safety And Cost Comparisons" - Pink Sheet, 24 Feb, 2005.)).

- Andrew Shelton

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel